[1]
Quaglia, F.M. et al. 2019. Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Aug. 2019), e2019057. DOI:https://doi.org/10.4084/mjhid.2019.057.